Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) Given Consensus Recommendation of “Reduce” by Analysts

Shares of Aveanna Healthcare Holdings Inc. (NASDAQ:AVAHGet Free Report) have received an average rating of “Reduce” from the five analysts that are covering the stock, Marketbeat.com reports. Three investment analysts have rated the stock with a sell rating, one has assigned a hold rating and one has assigned a buy rating to the company. The average twelve-month price target among brokerages that have updated their coverage on the stock in the last year is $1.80.

Separately, Deutsche Bank Aktiengesellschaft increased their price target on Aveanna Healthcare from $2.00 to $3.00 and gave the company a “buy” rating in a research report on Monday, March 18th.

Read Our Latest Analysis on Aveanna Healthcare

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently modified their holdings of the company. Mackenzie Financial Corp acquired a new stake in Aveanna Healthcare in the 3rd quarter valued at about $36,000. SG Americas Securities LLC raised its stake in Aveanna Healthcare by 24.6% in the fourth quarter. SG Americas Securities LLC now owns 23,941 shares of the company’s stock valued at $64,000 after buying an additional 4,721 shares during the period. Acadian Asset Management LLC lifted its position in shares of Aveanna Healthcare by 185.6% in the first quarter. Acadian Asset Management LLC now owns 29,385 shares of the company’s stock valued at $72,000 after buying an additional 19,096 shares during the last quarter. King Street Capital Management L.P. boosted its stake in shares of Aveanna Healthcare by 11.8% during the 3rd quarter. King Street Capital Management L.P. now owns 4,250,000 shares of the company’s stock worth $5,058,000 after acquiring an additional 450,000 shares during the period. Finally, Vanguard Group Inc. increased its holdings in shares of Aveanna Healthcare by 1.8% during the 1st quarter. Vanguard Group Inc. now owns 2,571,251 shares of the company’s stock worth $6,402,000 after acquiring an additional 44,970 shares during the last quarter. Institutional investors own 87.96% of the company’s stock.

Aveanna Healthcare Stock Down 0.8 %

NASDAQ AVAH opened at $2.48 on Tuesday. Aveanna Healthcare has a 12-month low of $0.85 and a 12-month high of $3.00. The firm’s 50 day moving average is $2.38 and its 200-day moving average is $2.34. The company has a market capitalization of $477.10 million, a PE ratio of -4.13 and a beta of 2.02.

Aveanna Healthcare (NASDAQ:AVAHGet Free Report) last issued its quarterly earnings results on Thursday, May 9th. The company reported ($0.05) EPS for the quarter, topping the consensus estimate of ($0.06) by $0.01. The business had revenue of $490.65 million for the quarter, compared to the consensus estimate of $485.05 million. During the same period last year, the firm earned ($0.06) earnings per share. As a group, sell-side analysts expect that Aveanna Healthcare will post -0.14 EPS for the current year.

Aveanna Healthcare Company Profile

(Get Free Report

Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.

Recommended Stories

Analyst Recommendations for Aveanna Healthcare (NASDAQ:AVAH)

Receive News & Ratings for Aveanna Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aveanna Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.